To conclude, in this study, we showed that consumption of 4 g of a CPH daily for 8 weeks in individuals with MetS had no effect on fasting or postprandial glucose, insulin levels or GLP-1 levels, lipid profile or body composition. This evidence concerns the gene INS and metabolic syndrome.